P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | April 4, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |